Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)
Aztreonam-avibactam may represent a valuable option to treat S. maltophilia infections, addressing a major unmet medical need.
Authors
- Rodrigo E. Mendes (ORCID: https://orcid.org/0000-0002-8648-1137)
- Timothy B Doyle (ORCID: https://orcid.org/0000-0002-1083-8742)
- Marisa Winkler (ORCID: https://orcid.org/0000-0002-9785-5034)
- Hélio S. Sader (ORCID: https://orcid.org/0000-0001-7022-6644)
- Mariana Castanheira
Institutions
- JMI Laboratories (US)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ijid.2025.107803
- Citations
- 9
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 16.18
Funders
- Pfizer